WT1 and breast cancer: In addition, Wu et al. 41 reported that among 389,795 WT1 SNPs associated with pCR, rs6044100 and rs1799937 were significantly associated with pCR after neoadjuvant chemotherapy, suggesting that WT1 may be a potential target in breast cancer.